Clinical Trials on Mycobacterium Tuberculosis, Protection Against in Belgium

Total 7 results

GlaxoSmithKline

Completed

Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02 in Healthy PPD-negative Adults.

Tuberculosis (TB)

Belgium
Centre Hospitalier Universitaire Saint Pierre

Completed

Induced Sputum Versus Bronchoscopy in Smear Negative Pulmonary Tuberculosis

Pulmonary Tuberculosis

Belgium
GlaxoSmithKline

Completed

Safety and Immunogenicity of 2 Formulations of Tuberculosis Vaccine GSK692342 Given at 0,1 Months to Healthy Adults

Tuberculosis

Belgium
GlaxoSmithKline
Aeras

Completed

Study in Healthy Adults to Evaluate Gene Activation After Vaccination With GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342

Tuberculosis

Belgium
Centre Hospitalier Universitaire Saint Pierre

Suspended

Role of EBUS-TBNA in Diagnosing TB in Mediastinal/Hilar Lymph Nodes

Tuberculosis

Belgium
Dissou AFFOLABI
London School of Hygiene and Tropical Medicine; World Health Organization; Institute... and other collaborators

Completed

DIAgnostics for Multidrug Resistant Tuberculosis in Africa (DIAMA)

Tuberculosis, Multidrug-Resistant

Belgium, Benin, Cameroon, Congo, The Democratic Republic of the, Ethiopia, Guinea, Mali, Nigeria, Rwanda, Senegal
Laboratoire de Référence des Mycobactéries
Institute of Tropical Medicine, Belgium; Universiteit Antwerpen; Direction Générale... and other collaborators

Completed

Benin Population Diversity of Tuberculosis and Implications (BeniDiT)

Tuberculosis

Benin, Belgium

3

Subscribe